Else Kröner Fresenius Foundation supports new research center for optogenetic therapies with 37.4 million euros over ten years at the University Medical Center Göttingen (UMG). State of Lower Saxony is strongly supporting the establishment of the center and, together with the UMG, is holding out the prospect of up to 22.6 million euros in additional funding. The new research building with costs of 32.7 million euros will be included in the construction planning by the state of Lower Saxony. The aim of the center is to develop innovative treatment approaches for patients suffering from deafness, blindness, gastric paralysis or movement deficits. The center will be integrated into the UMG.
from Pressemitteilungen – idw – Informationsdienst Wissenschaft https://ift.tt/AbnVhXN